These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10448832)

  • 21. [Determinants of tiagabine (TGB) efficacy and safety. A Polish multicenter study of 1307 patients with focal epilepsy].
    Kozik A; Krause M
    Neurol Neurochir Pol; 2003; 37(3):537-46. PubMed ID: 14593750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient athetosis induced by tiagabine.
    Tombini M; Pacifici L; Passarelli F; Rossini PM
    Epilepsia; 2006 Apr; 47(4):799-800. PubMed ID: 16650148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seizure activity and off-label use of tiagabine.
    Flowers CM; Racoosin JA; Kortepeter C
    N Engl J Med; 2006 Feb; 354(7):773-4. PubMed ID: 16481654
    [No Abstract]   [Full Text] [Related]  

  • 24. Tiagabine (gabitril) experience in children.
    Pellock JM
    Epilepsia; 2001; 42 Suppl 3():49-51. PubMed ID: 11520324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characteristics and indications of tiagabine].
    Casas-Fernández C; Domingo-Jiménez R
    Rev Neurol; 2002 Sep; 35 Suppl 1():S96-S100. PubMed ID: 12373661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Status epilepticus due to tiagabine ingestion.
    Leikin JB; Benigno J; Dubow JS; Fisher M
    Am J Ther; 2008; 15(3):290-1. PubMed ID: 18496267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tiagabine for epilepsy.
    Med Lett Drugs Ther; 1998 Apr; 40(1024):45-6. PubMed ID: 9580745
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine.
    Walton NY; Gunawan S; Treiman DM
    Epilepsy Res; 1994 Dec; 19(3):237-44. PubMed ID: 7698100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tiagabine in clinical practice.
    Genton P; Guerrini R; Perucca E
    Epilepsia; 2001; 42 Suppl 3():42-5. PubMed ID: 11520322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Provocation of non-convulsive status epilepticus by tiagabine in three adolescent patients.
    Balslev T; Uldall P; Buchholt J
    Eur J Paediatr Neurol; 2000; 4(4):169-70. PubMed ID: 11008259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tiagabine approved for partial seizures.
    Am J Health Syst Pharm; 1997 Nov; 54(22):2544. PubMed ID: 9397209
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-induced status epilepticus.
    Cock HR
    Epilepsy Behav; 2015 Aug; 49():76-82. PubMed ID: 26210064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tiagabine.
    Leach JP; Brodie MJ
    Lancet; 1998 Jan; 351(9097):203-7. PubMed ID: 9449883
    [No Abstract]   [Full Text] [Related]  

  • 34. GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy.
    Chmielewska B; Stelmasiak Z
    Neurol Neurochir Pol; 2008; 42(4):303-11. PubMed ID: 18975234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term safety of tiagabine.
    Kälviäinen R
    Epilepsia; 2001; 42 Suppl 3():46-8. PubMed ID: 11520323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and EEG findings in complex partial status epilepticus with tiagabine.
    Trinka E; Moroder T; Nagler M; Staffen W; Löscher W; Ladurner G
    Seizure; 1999 Feb; 8(1):41-4. PubMed ID: 10091848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experience with tiagabine in the clinical practice; new insights as to the efficacy and safety profile].
    Kellinghaus C; Loddenkemper T; Weitemeyer L; Lüdemann P
    Nervenarzt; 2001 Oct; 72(10):764-9. PubMed ID: 11688177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and EEG findings in complex partial status epilepticus with tiagabine.
    Steinhoff BJ; Eckardt KM
    Seizure; 1999 May; 8(3):197. PubMed ID: 10356385
    [No Abstract]   [Full Text] [Related]  

  • 39. [Open study with tiagabine in partial epilepsy].
    Arroyo S
    Rev Neurol; 2000 Oct 16-31; 31(8):728-32. PubMed ID: 11082879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of controlled trials of gabitril (tiagabine): a clinician's viewpoint.
    Loiseau P
    Epilepsia; 1999; 40 Suppl 9():S14-9. PubMed ID: 10612357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.